IGF-1 LR3 and MK-677 Interaction

Monitor
Researched 90% confidence

IGF-1 LR3 and MK-677 have an interaction requiring monitoring for interaction with 90% confidence. May compound metabolic effects through GH stimulation. Both compounds affect the pituitary, so monitoring these systems is recommended.

Compound Profiles

IGF-1 LR3

Modified Growth Factor Analog | Muscle Growth

Functions as a full IGF-1 receptor agonist activating PI3K/Akt/mTOR and MAPK/ERK pathways. The modifications prevent protein sequestration, maintaining elevated free circulating levels for extended anabolic effects.

Half-life: 20-30 hours Typical dose: 20-100 mcg daily (start low at 20-30 mcg) growth hormone, healing
igf1mtor carcinogenic riskinsulin disrupting
View full profile

MK-677

Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue

Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..

Half-life: ~24 hours Typical dose: Start 12.5mg daily, increase to 25mg based on tolerance growth hormone, weight loss, sleep
ghrelin receptor blood pressure raisingcarcinogenic riskhepatotoxicinsulin disrupting
View full profile

Combined Organ Load

Pituitary
low
Blood Vessels
low
Brain
low
GI Tract
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (IGF-1 LR3, MK-677). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (IGF-1 LR3, MK-677). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take IGF-1 LR3 with MK-677?

Yes, but with caution. May compound metabolic effects through GH stimulation. Regular monitoring is advised.

Is IGF-1 LR3 and MK-677 safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting. Monitor accordingly.

What are the interactions between IGF-1 LR3 and MK-677?

May compound metabolic effects through GH stimulation. This assessment has 90% confidence and is based on documented research data.

How should I time IGF-1 LR3 and MK-677?

IGF-1 LR3 has a half-life of 20-30 hours and MK-677 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: IGF-1 LR3 vs MK-677

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.